Pot Professor Studies Cannabis for Opioid Addiction as Major Drugmakers Face Lawsuits

published on September 5, 2019 by Jared Gnam in Mugglehead

While pharmaceutical giants are being forced in the U.S. to hand over millions of dollars for their role in fueling the opioid crisis, Canada’s first-ever pot professor is leading clinical trials to explore how cannabis might help people fighting opioid addiction.

In late August, an Oklahoma judge ordered Johnson & Johnson to pay US$572 million for driving the opioid epidemic by deceptively marketing addictive painkillers. The landmark decision will have widespread consequences for other major drugmakers facing roughly 2,500 lawsuits filed by numerous U.S. jurisdictions seeking to hold the companies responsible for their role in creating opioid abuse…

View the full article